Wolfgang Miesbach: From genes to mechanisms – An Outstanding Update on Inherited Platelet Disorders
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“From genes to mechanisms.
An outstanding update on inherited platelet disorders (IPD) by Paolo Gresele and Loredana Bury at the EHA-SWG Scientific Meeting on Bleeding and Platelet Disorders in Florence.
Inherited platelet disorders were presented as heterogeneous group of bleeding disorders, encompassing both inherited thrombocytopenias (IPND) and inherited platelet function disorders (IPFD), driven by defects in megakaryocyte maturation, pro‑platelet formation, signalling pathways, granule biology, membrane receptors, transcription factors and the cytoskeleton.
The speakers offered a very practical clinical classification, distinguishing isolated thrombocytopenia, thrombocytopenia with additional congenital anomalies and predisposition syndromes, and highlighted syndromic forms with multi‑organ involvement as well as the broad spectrum of platelet function defects and their impact on bleeding.
Data from large cohorts, including surgical series, clearly show that patients with IPD have a significantly increased risk of peri‑procedural bleeding – especially in cardiovascular, urologic, gynecologic, ENT and plastic surgery – and that women are particularly affected by heavy menstrual and obstetric bleeding, with major consequences for quality of life.
Structured bleeding assessment, standardized platelet function testing and modern genetic diagnostics are essential to stratify bleeding risk, recognize syndromic forms early, guide peri‑operative management and enable informed genetic counselling – laying the groundwork for more individualized, mechanism‑based therapies in the future.”

Other posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Jul 7, 2026, 06:19Simone Schoenwaelder: Women Are 25% More Likely to Have Their Stroke Misdiagnosed and Here’s Why
-
Jul 7, 2026, 06:12Dhiraj Bhatia: Extremely Happy to Share Our Review on DNA Nanotechnology in Stroke Repair
-
Jul 7, 2026, 06:04Brian A Beh: An Open Letter to Lisa Murphy Honouring the 30 Years of the Stroke Foundation’s Dedication
-
Jul 7, 2026, 05:55Alan Nurden: A Landmark Review Comparing Hemophilia and Hereditary Angioedema
-
Jul 7, 2026, 05:40Andrew Agwunobi: UConn Health is Proud to Advance Stroke Rehabilitation for Veterans
-
Jul 6, 2026, 22:54Louise St. Germain Bannon: I Wanted to Recognize the Incredible Staff Behind ISTH 2026
-
Jul 6, 2026, 21:46Armghan Ans: UPMC Washington Stroke Program Earns AHA Gold Plus Award for 16th Consecutive Year
-
Jul 6, 2026, 20:31Manik Madaan: Master Transfusion Reactions for USMLE In Less Than 60 Seconds
-
Jul 6, 2026, 19:25Ambreen Kashif: Highlighting the Impact of Temporary Donor Deferrals on Donor Retention